PharVision Advisers’s HNI Corp HNI Stock Holding History

PharVision Advisers’s Portfolio HNI Stock Details HNI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,961	Closed	-$264K	–	344
2025 Q1	$264K	Buy	+5,961	New	+$282K	0.37%	122

Other funds holding HNI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PharVision Advisers's HNI Position: Q2 2025 in Review

PharVision Advisers sold out of HNI Corp (HNI) in Q2 2025, closing a stake of 5,961 shares — an estimated $264K sold.

PharVision Advisers first reported a position in HNI in Q1 2025 and held it in 1 quarter. The position peaked at $264K in Q1 2025. 250 funds tracked by Wall St. Rank hold HNI as of Q2 2025.

PharVision Advisers reported no remaining HNI Corp position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 5,961 HNI Corp shares in Q2 2025, an estimated $264K.
PharVision Advisers first reported a position in HNI Corp in Q1 2025 and held it in 1 quarter.
PharVision Advisers's HNI Corp position peaked at $264K in Q1 2025.
250 funds tracked by Wall St. Rank held HNI Corp as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.